| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurosurgical Procedures | 12 | 2017 | 213 | 3.910 |
Why?
|
| Hydrocephalus | 7 | 2016 | 101 | 2.650 |
Why?
|
| Postoperative Complications | 16 | 2018 | 2207 | 2.420 |
Why?
|
| Spinal Fusion | 10 | 2018 | 85 | 2.360 |
Why?
|
| Craniosynostoses | 5 | 2017 | 77 | 2.320 |
Why?
|
| Third Ventricle | 4 | 2016 | 11 | 2.130 |
Why?
|
| Spinal Cord Neoplasms | 5 | 2015 | 48 | 2.070 |
Why?
|
| Neuroendoscopy | 5 | 2016 | 14 | 1.820 |
Why?
|
| Databases, Factual | 15 | 2018 | 814 | 1.810 |
Why?
|
| Infant | 31 | 2017 | 3046 | 1.710 |
Why?
|
| Ventriculostomy | 4 | 2016 | 26 | 1.700 |
Why?
|
| Arnold-Chiari Malformation | 4 | 2016 | 43 | 1.600 |
Why?
|
| Meningomyelocele | 3 | 2016 | 19 | 1.570 |
Why?
|
| Ventriculoperitoneal Shunt | 3 | 2016 | 22 | 1.510 |
Why?
|
| Hospitalization | 7 | 2017 | 849 | 1.400 |
Why?
|
| Adolescent | 43 | 2017 | 8981 | 1.400 |
Why?
|
| Astrocytoma | 3 | 2014 | 82 | 1.380 |
Why?
|
| Male | 85 | 2018 | 40965 | 1.360 |
Why?
|
| Cerebrospinal Fluid Shunts | 4 | 2015 | 48 | 1.340 |
Why?
|
| Craniotomy | 5 | 2016 | 88 | 1.300 |
Why?
|
| Female | 85 | 2018 | 44532 | 1.260 |
Why?
|
| Antibiotic Prophylaxis | 3 | 2017 | 71 | 1.210 |
Why?
|
| Plagiocephaly, Nonsynostotic | 2 | 2017 | 3 | 1.200 |
Why?
|
| Child, Preschool | 26 | 2017 | 3612 | 1.190 |
Why?
|
| Orthotic Devices | 2 | 2017 | 9 | 1.190 |
Why?
|
| Spinal Diseases | 4 | 2018 | 44 | 1.190 |
Why?
|
| Child | 34 | 2017 | 6927 | 1.160 |
Why?
|
| Vagus Nerve Stimulation | 2 | 2017 | 9 | 1.160 |
Why?
|
| Spine | 4 | 2015 | 102 | 1.130 |
Why?
|
| Surgical Wound Infection | 6 | 2018 | 184 | 1.120 |
Why?
|
| Skull | 5 | 2015 | 249 | 1.110 |
Why?
|
| Anti-Bacterial Agents | 8 | 2017 | 746 | 1.090 |
Why?
|
| Decompression, Surgical | 7 | 2016 | 87 | 1.070 |
Why?
|
| Cervical Vertebrae | 10 | 2018 | 79 | 1.060 |
Why?
|
| Ependymoma | 2 | 2015 | 17 | 1.040 |
Why?
|
| Humans | 103 | 2018 | 86643 | 1.040 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2015 | 37 | 1.020 |
Why?
|
| Hospital Costs | 2 | 2016 | 105 | 1.020 |
Why?
|
| Treatment Outcome | 30 | 2018 | 7993 | 0.940 |
Why?
|
| Helicobacter Infections | 6 | 2003 | 34 | 0.890 |
Why?
|
| Helicobacter pylori | 6 | 2003 | 35 | 0.880 |
Why?
|
| Transforming Growth Factor beta | 2 | 2015 | 301 | 0.880 |
Why?
|
| Duodenal Ulcer | 6 | 2003 | 11 | 0.870 |
Why?
|
| Retrospective Studies | 32 | 2018 | 8489 | 0.810 |
Why?
|
| Epilepsy | 2 | 2016 | 397 | 0.800 |
Why?
|
| Reoperation | 4 | 2016 | 597 | 0.790 |
Why?
|
| Young Adult | 16 | 2016 | 5976 | 0.790 |
Why?
|
| United States | 14 | 2016 | 6672 | 0.760 |
Why?
|
| Pediatrics | 4 | 2017 | 344 | 0.750 |
Why?
|
| Infant, Newborn | 13 | 2017 | 2379 | 0.750 |
Why?
|
| Quality Improvement | 4 | 2017 | 428 | 0.740 |
Why?
|
| Registries | 2 | 2014 | 702 | 0.740 |
Why?
|
| Length of Stay | 11 | 2017 | 702 | 0.730 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2015 | 582 | 0.690 |
Why?
|
| Frontal Bone | 2 | 2015 | 16 | 0.670 |
Why?
|
| Craniocerebral Trauma | 2 | 2017 | 52 | 0.660 |
Why?
|
| Cranial Fossa, Posterior | 2 | 2016 | 25 | 0.650 |
Why?
|
| Follow-Up Studies | 15 | 2017 | 3640 | 0.650 |
Why?
|
| Airway Obstruction | 2 | 2016 | 109 | 0.640 |
Why?
|
| Hematoma | 2 | 2015 | 104 | 0.620 |
Why?
|
| Mydriasis | 1 | 2017 | 2 | 0.620 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2017 | 8 | 0.610 |
Why?
|
| Middle Aged | 42 | 2018 | 25028 | 0.610 |
Why?
|
| Craniopharyngioma | 1 | 2017 | 11 | 0.600 |
Why?
|
| Spinal Neoplasms | 2 | 2014 | 50 | 0.600 |
Why?
|
| Tuberculosis, Oral | 1 | 2016 | 1 | 0.580 |
Why?
|
| Pituitary Neoplasms | 1 | 2017 | 62 | 0.580 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2016 | 5 | 0.580 |
Why?
|
| Cohort Studies | 8 | 2018 | 2767 | 0.570 |
Why?
|
| Sialadenitis | 1 | 2016 | 8 | 0.570 |
Why?
|
| Aortic Diseases | 1 | 2017 | 100 | 0.570 |
Why?
|
| Airway Extubation | 1 | 2016 | 13 | 0.570 |
Why?
|
| Inpatients | 2 | 2018 | 297 | 0.560 |
Why?
|
| Cerebrovascular Disorders | 1 | 2017 | 143 | 0.560 |
Why?
|
| Physical Therapy Modalities | 1 | 2017 | 84 | 0.560 |
Why?
|
| Nervous System Diseases | 1 | 2017 | 151 | 0.560 |
Why?
|
| Risk Factors | 13 | 2018 | 5417 | 0.560 |
Why?
|
| Aged | 38 | 2018 | 18415 | 0.550 |
Why?
|
| Fever | 2 | 2015 | 125 | 0.550 |
Why?
|
| Seasons | 1 | 2017 | 223 | 0.550 |
Why?
|
| Orbital Cellulitis | 1 | 2015 | 4 | 0.550 |
Why?
|
| Sphenoid Bone | 1 | 2015 | 9 | 0.540 |
Why?
|
| Neurocysticercosis | 1 | 2015 | 7 | 0.540 |
Why?
|
| Patient Compliance | 2 | 2017 | 227 | 0.540 |
Why?
|
| Eye Infections, Bacterial | 1 | 2015 | 14 | 0.540 |
Why?
|
| Neurosurgery | 2 | 2016 | 84 | 0.530 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2015 | 860 | 0.530 |
Why?
|
| Cranial Sutures | 1 | 2015 | 47 | 0.530 |
Why?
|
| Age Factors | 12 | 2015 | 1851 | 0.520 |
Why?
|
| Perioperative Care | 1 | 2017 | 161 | 0.520 |
Why?
|
| Hemispherectomy | 1 | 2014 | 2 | 0.520 |
Why?
|
| Encephalitis | 1 | 2015 | 104 | 0.520 |
Why?
|
| Papilloma, Choroid Plexus | 1 | 2014 | 1 | 0.520 |
Why?
|
| Choroid Plexus Neoplasms | 1 | 2014 | 2 | 0.520 |
Why?
|
| Electrodes, Implanted | 1 | 2016 | 171 | 0.520 |
Why?
|
| Hamartoma | 1 | 2015 | 31 | 0.520 |
Why?
|
| Neural Crest | 1 | 2015 | 25 | 0.520 |
Why?
|
| Pneumococcal Infections | 1 | 2015 | 46 | 0.520 |
Why?
|
| Cerebral Aqueduct | 1 | 2014 | 1 | 0.510 |
Why?
|
| Venous Thromboembolism | 2 | 2015 | 153 | 0.510 |
Why?
|
| Spina Bifida Occulta | 1 | 2014 | 6 | 0.510 |
Why?
|
| Adult | 37 | 2018 | 25648 | 0.500 |
Why?
|
| Dermoid Cyst | 1 | 2014 | 15 | 0.500 |
Why?
|
| Brain Injuries | 2 | 2014 | 161 | 0.500 |
Why?
|
| Models, Economic | 1 | 2014 | 60 | 0.500 |
Why?
|
| Blood Transfusion | 2 | 2015 | 157 | 0.490 |
Why?
|
| Costs and Cost Analysis | 1 | 2014 | 153 | 0.490 |
Why?
|
| Lumbar Vertebrae | 4 | 2016 | 148 | 0.490 |
Why?
|
| Drug Delivery Systems | 1 | 2015 | 178 | 0.490 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 2014 | 19 | 0.490 |
Why?
|
| Brain Stem Neoplasms | 1 | 2014 | 17 | 0.480 |
Why?
|
| Infant, Premature, Diseases | 1 | 2014 | 78 | 0.480 |
Why?
|
| Laminectomy | 2 | 2014 | 27 | 0.480 |
Why?
|
| Syringomyelia | 3 | 2012 | 15 | 0.470 |
Why?
|
| Hyperhidrosis | 1 | 2013 | 10 | 0.470 |
Why?
|
| Psoas Abscess | 1 | 2013 | 2 | 0.460 |
Why?
|
| Decompressive Craniectomy | 1 | 2013 | 18 | 0.460 |
Why?
|
| Glioblastoma | 1 | 2015 | 255 | 0.450 |
Why?
|
| Meconium | 1 | 2012 | 15 | 0.450 |
Why?
|
| Transplantation, Autologous | 1 | 2014 | 331 | 0.450 |
Why?
|
| Deep Brain Stimulation | 1 | 2013 | 54 | 0.440 |
Why?
|
| Prospective Studies | 14 | 2016 | 4213 | 0.440 |
Why?
|
| Biocompatible Materials | 1 | 2014 | 193 | 0.430 |
Why?
|
| Multivariate Analysis | 5 | 2015 | 999 | 0.430 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 322 | 0.430 |
Why?
|
| Occipital Bone | 4 | 2015 | 18 | 0.430 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 508 | 0.420 |
Why?
|
| Parkinson Disease | 1 | 2013 | 132 | 0.420 |
Why?
|
| Population Surveillance | 1 | 2013 | 219 | 0.420 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2017 | 579 | 0.420 |
Why?
|
| Brain Stem | 1 | 2012 | 165 | 0.420 |
Why?
|
| Carcinoma | 1 | 2014 | 436 | 0.390 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 371 | 0.380 |
Why?
|
| Drug Therapy, Combination | 4 | 2017 | 894 | 0.380 |
Why?
|
| Staphylococcal Infections | 1 | 2013 | 255 | 0.370 |
Why?
|
| Peptic Ulcer Hemorrhage | 4 | 2000 | 9 | 0.370 |
Why?
|
| Time Factors | 8 | 2018 | 5210 | 0.370 |
Why?
|
| Prognosis | 10 | 2015 | 3679 | 0.370 |
Why?
|
| Thoracic Vertebrae | 4 | 2015 | 49 | 0.370 |
Why?
|
| Staphylococcus aureus | 1 | 2013 | 263 | 0.370 |
Why?
|
| Diagnosis, Differential | 6 | 2016 | 1565 | 0.360 |
Why?
|
| Respiration, Artificial | 1 | 2012 | 334 | 0.360 |
Why?
|
| SEER Program | 3 | 2015 | 190 | 0.360 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 763 | 0.350 |
Why?
|
| Brain | 2 | 2017 | 2216 | 0.350 |
Why?
|
| Patient Readmission | 3 | 2018 | 329 | 0.340 |
Why?
|
| Stomach Ulcer | 3 | 2003 | 23 | 0.300 |
Why?
|
| Diskectomy | 3 | 2018 | 20 | 0.300 |
Why?
|
| Aged, 80 and over | 15 | 2016 | 6509 | 0.300 |
Why?
|
| Bone Transplantation | 4 | 2015 | 64 | 0.300 |
Why?
|
| Computer-Aided Design | 1 | 2017 | 18 | 0.300 |
Why?
|
| Incidence | 4 | 2016 | 1577 | 0.300 |
Why?
|
| Endoscopy, Gastrointestinal | 5 | 2003 | 153 | 0.290 |
Why?
|
| Parietal Bone | 3 | 2016 | 20 | 0.290 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2016 | 2601 | 0.280 |
Why?
|
| Minimally Invasive Surgical Procedures | 4 | 2015 | 237 | 0.280 |
Why?
|
| Scalp | 2 | 2017 | 72 | 0.280 |
Why?
|
| Survival Rate | 4 | 2014 | 1863 | 0.270 |
Why?
|
| Omeprazole | 2 | 2003 | 11 | 0.270 |
Why?
|
| Anti-Ulcer Agents | 2 | 2003 | 22 | 0.270 |
Why?
|
| Spinal Cord Compression | 2 | 2015 | 27 | 0.260 |
Why?
|
| Spondylolisthesis | 2 | 2015 | 12 | 0.260 |
Why?
|
| Cross-Sectional Studies | 3 | 2015 | 1621 | 0.260 |
Why?
|
| Skull Fractures | 2 | 2015 | 24 | 0.260 |
Why?
|
| Intervertebral Disc Degeneration | 2 | 2015 | 6 | 0.250 |
Why?
|
| Hong Kong | 6 | 2013 | 45 | 0.250 |
Why?
|
| Surveys and Questionnaires | 6 | 2015 | 2501 | 0.250 |
Why?
|
| Disability Evaluation | 3 | 2013 | 136 | 0.250 |
Why?
|
| Publishing | 2 | 2016 | 90 | 0.240 |
Why?
|
| Odds Ratio | 3 | 2015 | 678 | 0.240 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2015 | 292 | 0.240 |
Why?
|
| Spondylosis | 2 | 2013 | 4 | 0.230 |
Why?
|
| Pain Measurement | 3 | 2013 | 321 | 0.230 |
Why?
|
| Neoplasm Grading | 2 | 2015 | 357 | 0.230 |
Why?
|
| Spinal Fractures | 2 | 2014 | 75 | 0.230 |
Why?
|
| Sex Factors | 4 | 2015 | 1054 | 0.220 |
Why?
|
| Logistic Models | 3 | 2015 | 1186 | 0.210 |
Why?
|
| Esophagitis, Peptic | 1 | 2002 | 10 | 0.210 |
Why?
|
| Chest Pain | 1 | 2002 | 42 | 0.210 |
Why?
|
| Cholangitis | 1 | 2001 | 19 | 0.210 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2001 | 62 | 0.200 |
Why?
|
| Quality of Life | 5 | 2017 | 1585 | 0.200 |
Why?
|
| Emergencies | 2 | 2001 | 113 | 0.200 |
Why?
|
| Antacids | 1 | 2000 | 4 | 0.190 |
Why?
|
| Pain | 2 | 2013 | 391 | 0.190 |
Why?
|
| Benzimidazoles | 1 | 2001 | 140 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2017 | 3362 | 0.190 |
Why?
|
| Blood Loss, Surgical | 3 | 2015 | 112 | 0.190 |
Why?
|
| Gastroesophageal Reflux | 1 | 2002 | 117 | 0.180 |
Why?
|
| Neoplasm Staging | 4 | 2014 | 1939 | 0.180 |
Why?
|
| Operative Time | 2 | 2016 | 127 | 0.170 |
Why?
|
| Outpatients | 1 | 2018 | 94 | 0.150 |
Why?
|
| ROC Curve | 3 | 2014 | 752 | 0.150 |
Why?
|
| Treatment Failure | 2 | 2014 | 285 | 0.150 |
Why?
|
| Actins | 2 | 2017 | 451 | 0.150 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2003 | 243 | 0.140 |
Why?
|
| Gonadal Dysgenesis | 1 | 1996 | 3 | 0.140 |
Why?
|
| Cystadenoma, Mucinous | 1 | 1996 | 7 | 0.140 |
Why?
|
| Bibliometrics | 1 | 2016 | 37 | 0.140 |
Why?
|
| Fasciitis | 1 | 2016 | 10 | 0.140 |
Why?
|
| Baclofen | 1 | 2015 | 15 | 0.140 |
Why?
|
| Muscle Relaxants, Central | 1 | 2015 | 10 | 0.140 |
Why?
|
| Microsurgery | 2 | 2013 | 84 | 0.140 |
Why?
|
| Anthelmintics | 1 | 2015 | 6 | 0.140 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2016 | 42 | 0.140 |
Why?
|
| After-Hours Care | 1 | 2015 | 8 | 0.140 |
Why?
|
| Recombinant Proteins | 2 | 2015 | 1014 | 0.140 |
Why?
|
| Forehead | 1 | 2015 | 15 | 0.140 |
Why?
|
| Amygdala | 1 | 2016 | 84 | 0.130 |
Why?
|
| Esthetics | 1 | 2015 | 44 | 0.130 |
Why?
|
| Enoxaparin | 1 | 2015 | 23 | 0.130 |
Why?
|
| Airway Management | 1 | 2016 | 46 | 0.130 |
Why?
|
| Health Facility Size | 1 | 2015 | 9 | 0.130 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2015 | 29 | 0.130 |
Why?
|
| Orbit | 1 | 2015 | 37 | 0.130 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2015 | 16 | 0.130 |
Why?
|
| Health Care Costs | 2 | 2016 | 238 | 0.130 |
Why?
|
| Specialties, Surgical | 1 | 2016 | 64 | 0.130 |
Why?
|
| Elective Surgical Procedures | 1 | 2016 | 116 | 0.130 |
Why?
|
| Accidental Falls | 1 | 2015 | 50 | 0.130 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2015 | 126 | 0.130 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 364 | 0.130 |
Why?
|
| Spinal Curvatures | 1 | 2014 | 7 | 0.130 |
Why?
|
| Hospitals, Pediatric | 1 | 2015 | 106 | 0.130 |
Why?
|
| Cysts | 1 | 2015 | 104 | 0.130 |
Why?
|
| Social Class | 1 | 2015 | 128 | 0.130 |
Why?
|
| Dyspnea | 1 | 2015 | 73 | 0.130 |
Why?
|
| Primary Prevention | 1 | 2015 | 85 | 0.130 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2015 | 865 | 0.120 |
Why?
|
| Neural Tube Defects | 1 | 2014 | 43 | 0.120 |
Why?
|
| Vertebroplasty | 1 | 2014 | 8 | 0.120 |
Why?
|
| Meningitis | 2 | 2015 | 20 | 0.120 |
Why?
|
| Free Tissue Flaps | 1 | 2015 | 49 | 0.120 |
Why?
|
| Vancomycin | 1 | 2014 | 72 | 0.120 |
Why?
|
| Venous Cutdown | 1 | 2014 | 2 | 0.120 |
Why?
|
| Geography | 1 | 2015 | 223 | 0.120 |
Why?
|
| Body Height | 1 | 2014 | 99 | 0.120 |
Why?
|
| Bone Matrix | 1 | 2014 | 18 | 0.120 |
Why?
|
| Fractures, Compression | 1 | 2014 | 17 | 0.120 |
Why?
|
| History, 19th Century | 1 | 2014 | 59 | 0.120 |
Why?
|
| Community Health Planning | 1 | 2014 | 21 | 0.120 |
Why?
|
| Amoxicillin | 3 | 2003 | 13 | 0.120 |
Why?
|
| Hemangioma | 1 | 2014 | 60 | 0.120 |
Why?
|
| Patient Acuity | 1 | 2014 | 32 | 0.120 |
Why?
|
| Insurance, Health | 1 | 2015 | 160 | 0.120 |
Why?
|
| Spinal Cord | 1 | 2015 | 249 | 0.120 |
Why?
|
| Patient Discharge | 1 | 1997 | 300 | 0.120 |
Why?
|
| Constriction, Pathologic | 1 | 2014 | 213 | 0.120 |
Why?
|
| Head Injuries, Closed | 1 | 2013 | 11 | 0.120 |
Why?
|
| Deglutition Disorders | 1 | 2015 | 115 | 0.120 |
Why?
|
| Case-Control Studies | 2 | 2017 | 1805 | 0.120 |
Why?
|
| Temporal Bone | 1 | 2014 | 66 | 0.120 |
Why?
|
| Intraoperative Complications | 1 | 2015 | 185 | 0.120 |
Why?
|
| Spinal Cord Diseases | 1 | 2013 | 29 | 0.120 |
Why?
|
| History, 21st Century | 1 | 2014 | 175 | 0.110 |
Why?
|
| Internet | 1 | 2015 | 312 | 0.110 |
Why?
|
| Foraminotomy | 1 | 2012 | 2 | 0.110 |
Why?
|
| Tomography Scanners, X-Ray Computed | 2 | 2017 | 20 | 0.110 |
Why?
|
| Intervertebral Disc Displacement | 1 | 2012 | 24 | 0.110 |
Why?
|
| Respiratory Paralysis | 1 | 2012 | 8 | 0.110 |
Why?
|
| Vocal Cord Paralysis | 1 | 2012 | 26 | 0.110 |
Why?
|
| Spinal Stenosis | 1 | 2012 | 26 | 0.110 |
Why?
|
| Models, Statistical | 1 | 2016 | 574 | 0.110 |
Why?
|
| History, 20th Century | 1 | 2014 | 312 | 0.110 |
Why?
|
| Hippocampus | 1 | 2016 | 442 | 0.110 |
Why?
|
| Laryngoscopy | 1 | 2012 | 44 | 0.110 |
Why?
|
| Tracheostomy | 1 | 2012 | 42 | 0.110 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 351 | 0.110 |
Why?
|
| Societies, Medical | 1 | 2016 | 572 | 0.110 |
Why?
|
| Enteral Nutrition | 1 | 2012 | 102 | 0.110 |
Why?
|
| Disabled Persons | 1 | 2013 | 67 | 0.110 |
Why?
|
| Gastrostomy | 1 | 2012 | 69 | 0.110 |
Why?
|
| Self Report | 1 | 2014 | 288 | 0.110 |
Why?
|
| Metronidazole | 2 | 2003 | 26 | 0.110 |
Why?
|
| Medulla Oblongata | 1 | 2012 | 89 | 0.100 |
Why?
|
| Anticoagulants | 1 | 2015 | 408 | 0.100 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 1204 | 0.100 |
Why?
|
| Bites and Stings | 1 | 2011 | 9 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2014 | 912 | 0.100 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2013 | 183 | 0.100 |
Why?
|
| Arthropods | 1 | 2011 | 28 | 0.100 |
Why?
|
| Anemia, Hypochromic | 1 | 1991 | 5 | 0.100 |
Why?
|
| Surgical Flaps | 1 | 2013 | 241 | 0.100 |
Why?
|
| Hospital Mortality | 1 | 2013 | 349 | 0.100 |
Why?
|
| Urban Population | 2 | 2002 | 213 | 0.100 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 546 | 0.090 |
Why?
|
| Intensive Care Units | 1 | 2013 | 373 | 0.090 |
Why?
|
| Patient Satisfaction | 1 | 2013 | 455 | 0.090 |
Why?
|
| Eosinophilia | 1 | 1990 | 84 | 0.090 |
Why?
|
| Employee Performance Appraisal | 1 | 2009 | 4 | 0.090 |
Why?
|
| Ovarian Neoplasms | 1 | 1996 | 744 | 0.090 |
Why?
|
| Subarachnoid Space | 1 | 2008 | 17 | 0.090 |
Why?
|
| Family Practice | 1 | 2009 | 84 | 0.080 |
Why?
|
| Predictive Value of Tests | 4 | 2018 | 1673 | 0.080 |
Why?
|
| Quality Indicators, Health Care | 1 | 2009 | 144 | 0.080 |
Why?
|
| Antibodies, Viral | 2 | 1985 | 293 | 0.080 |
Why?
|
| Biometry | 1 | 2017 | 66 | 0.070 |
Why?
|
| Obesity | 1 | 2013 | 963 | 0.070 |
Why?
|
| Clarithromycin | 2 | 2003 | 7 | 0.070 |
Why?
|
| Dyspepsia | 2 | 2003 | 10 | 0.070 |
Why?
|
| Measles | 1 | 1985 | 15 | 0.070 |
Why?
|
| Measles Vaccine | 1 | 1985 | 7 | 0.070 |
Why?
|
| 2-Pyridinylmethylsulfinylbenzimidazoles | 2 | 2003 | 4 | 0.070 |
Why?
|
| Texas | 2 | 2015 | 101 | 0.070 |
Why?
|
| Immunization | 1 | 1985 | 158 | 0.070 |
Why?
|
| Glasgow Coma Scale | 2 | 2017 | 65 | 0.070 |
Why?
|
| Cerebellum | 1 | 2007 | 247 | 0.060 |
Why?
|
| Constipation | 1 | 2005 | 63 | 0.060 |
Why?
|
| Malaysia | 4 | 2002 | 12 | 0.060 |
Why?
|
| Vaccination | 1 | 1985 | 254 | 0.060 |
Why?
|
| Peptic Ulcer | 1 | 2003 | 19 | 0.060 |
Why?
|
| Secondary Prevention | 2 | 2003 | 162 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2009 | 751 | 0.060 |
Why?
|
| Esophagitis | 1 | 2002 | 42 | 0.060 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2000 | 375 | 0.060 |
Why?
|
| Liver Abscess | 1 | 2002 | 12 | 0.050 |
Why?
|
| Parvovirus B19, Human | 1 | 2002 | 3 | 0.050 |
Why?
|
| Heartburn | 1 | 2002 | 9 | 0.050 |
Why?
|
| Parvoviridae Infections | 1 | 2002 | 6 | 0.050 |
Why?
|
| Manometry | 1 | 2002 | 43 | 0.050 |
Why?
|
| Rabeprazole | 1 | 2001 | 1 | 0.050 |
Why?
|
| Proton-Translocating ATPases | 1 | 2001 | 23 | 0.050 |
Why?
|
| Prothrombin Time | 1 | 2001 | 20 | 0.050 |
Why?
|
| Acute Disease | 3 | 2001 | 826 | 0.050 |
Why?
|
| Herpesvirus 2, Human | 1 | 2002 | 45 | 0.050 |
Why?
|
| Bilirubin | 1 | 2001 | 125 | 0.050 |
Why?
|
| Exanthema | 1 | 2001 | 36 | 0.050 |
Why?
|
| China | 1 | 2002 | 228 | 0.050 |
Why?
|
| Albumins | 1 | 2001 | 133 | 0.050 |
Why?
|
| Prevalence | 2 | 2002 | 1239 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2005 | 1991 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2002 | 493 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2001 | 256 | 0.050 |
Why?
|
| Bismuth | 1 | 2000 | 8 | 0.050 |
Why?
|
| Diarrhea | 1 | 2001 | 182 | 0.050 |
Why?
|
| Herpes Simplex | 1 | 2002 | 202 | 0.050 |
Why?
|
| Cadherins | 1 | 2001 | 151 | 0.050 |
Why?
|
| Endoscopy, Digestive System | 1 | 2000 | 65 | 0.050 |
Why?
|
| Hemoglobins | 1 | 2000 | 179 | 0.050 |
Why?
|
| Pemphigoid, Benign Mucous Membrane | 1 | 1999 | 5 | 0.040 |
Why?
|
| Herpesvirus 1, Human | 1 | 2002 | 244 | 0.040 |
Why?
|
| Tetracycline | 1 | 1999 | 13 | 0.040 |
Why?
|
| Conjunctival Diseases | 1 | 1999 | 7 | 0.040 |
Why?
|
| Heart Rate | 1 | 2001 | 492 | 0.040 |
Why?
|
| Niacinamide | 1 | 1999 | 116 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2003 | 1823 | 0.040 |
Why?
|
| Drug Administration Schedule | 2 | 2015 | 916 | 0.040 |
Why?
|
| Stomach Neoplasms | 1 | 2001 | 266 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2001 | 971 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2013 | 596 | 0.040 |
Why?
|
| Mass Screening | 1 | 2002 | 618 | 0.040 |
Why?
|
| Delayed Diagnosis | 1 | 2017 | 29 | 0.040 |
Why?
|
| Edema | 1 | 2017 | 71 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 274 | 0.040 |
Why?
|
| Pneumonia | 1 | 2018 | 179 | 0.040 |
Why?
|
| Measles virus | 2 | 1985 | 14 | 0.030 |
Why?
|
| Search Engine | 1 | 2015 | 9 | 0.030 |
Why?
|
| Recurrence | 2 | 1997 | 1139 | 0.030 |
Why?
|
| Off-Label Use | 1 | 2015 | 16 | 0.030 |
Why?
|
| Factor Xa | 1 | 2015 | 4 | 0.030 |
Why?
|
| Atlanto-Axial Joint | 1 | 2015 | 8 | 0.030 |
Why?
|
| Myofibroblasts | 1 | 2016 | 43 | 0.030 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2015 | 10 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2015 | 117 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2000 | 797 | 0.030 |
Why?
|
| Morbidity | 1 | 2015 | 148 | 0.030 |
Why?
|
| Osteomyelitis | 1 | 2015 | 54 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2015 | 103 | 0.030 |
Why?
|
| Kyphoplasty | 1 | 2014 | 7 | 0.030 |
Why?
|
| Powders | 1 | 2014 | 74 | 0.030 |
Why?
|
| beta Catenin | 1 | 2016 | 251 | 0.030 |
Why?
|
| Periodicals as Topic | 1 | 2016 | 168 | 0.030 |
Why?
|
| Neck Pain | 1 | 2013 | 17 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2001 | 1169 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2016 | 464 | 0.030 |
Why?
|
| Visual Analog Scale | 1 | 2013 | 14 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2014 | 303 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 429 | 0.030 |
Why?
|
| Pennsylvania | 1 | 2013 | 75 | 0.030 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 1996 | 275 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1019 | 0.030 |
Why?
|
| Patient Outcome Assessment | 1 | 2013 | 84 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2015 | 328 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2001 | 1464 | 0.030 |
Why?
|
| Radiculopathy | 1 | 2012 | 15 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2013 | 111 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2016 | 729 | 0.030 |
Why?
|
| Medical Records | 1 | 2013 | 119 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 379 | 0.030 |
Why?
|
| Linear Models | 1 | 2013 | 421 | 0.030 |
Why?
|
| Cerebral Hemorrhage | 1 | 2015 | 325 | 0.030 |
Why?
|
| Puberty, Delayed | 1 | 1992 | 19 | 0.030 |
Why?
|
| Hydrotherapy | 1 | 2011 | 5 | 0.030 |
Why?
|
| Biopsy | 1 | 2016 | 1163 | 0.030 |
Why?
|
| Histamine Antagonists | 1 | 2011 | 12 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2013 | 272 | 0.030 |
Why?
|
| Cryotherapy | 1 | 2011 | 29 | 0.030 |
Why?
|
| Growth Disorders | 1 | 1992 | 63 | 0.030 |
Why?
|
| Graft Survival | 1 | 2015 | 884 | 0.030 |
Why?
|
| Asia, Southeastern | 1 | 1991 | 16 | 0.020 |
Why?
|
| Hematologic Tests | 1 | 1991 | 14 | 0.020 |
Why?
|
| Blood Specimen Collection | 1 | 1991 | 27 | 0.020 |
Why?
|
| Analgesics | 1 | 2011 | 119 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2000 | 2438 | 0.020 |
Why?
|
| Leukemia, Myeloid | 1 | 1992 | 249 | 0.020 |
Why?
|
| Chicago | 1 | 2015 | 1379 | 0.020 |
Why?
|
| Steroids | 1 | 2011 | 177 | 0.020 |
Why?
|
| Pain Management | 1 | 2011 | 127 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2013 | 770 | 0.020 |
Why?
|
| Administration, Oral | 2 | 2002 | 684 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2015 | 2261 | 0.020 |
Why?
|
| Headache | 1 | 2007 | 73 | 0.020 |
Why?
|
| Cause of Death | 2 | 2002 | 277 | 0.020 |
Why?
|
| Lansoprazole | 1 | 2003 | 2 | 0.020 |
Why?
|
| Esophageal Stenosis | 1 | 2002 | 26 | 0.010 |
Why?
|
| Esophagoscopy | 1 | 2002 | 87 | 0.010 |
Why?
|
| Seroepidemiologic Studies | 1 | 2002 | 55 | 0.010 |
Why?
|
| Barrett Esophagus | 1 | 2002 | 93 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2002 | 173 | 0.010 |
Why?
|
| Age Distribution | 1 | 2002 | 204 | 0.010 |
Why?
|
| Normal Distribution | 1 | 2001 | 37 | 0.010 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2001 | 41 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 2001 | 66 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2002 | 429 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2001 | 229 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2000 | 220 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 2000 | 156 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2001 | 376 | 0.010 |
Why?
|
| Comorbidity | 1 | 2002 | 943 | 0.010 |
Why?
|
| Pancreatitis | 1 | 1979 | 87 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2002 | 1801 | 0.010 |
Why?
|
| Peptic Ulcer Perforation | 1 | 1976 | 3 | 0.010 |
Why?
|
| Pyloric Stenosis | 1 | 1976 | 8 | 0.010 |
Why?
|
| ABO Blood-Group System | 1 | 1976 | 62 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2001 | 1376 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1996 | 695 | 0.010 |
Why?
|
| Animals | 1 | 2011 | 26582 | 0.010 |
Why?
|
| Smoking | 1 | 1976 | 609 | 0.010 |
Why?
|
| Gastroscopy | 1 | 1989 | 23 | 0.010 |
Why?
|